Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 117

    1.

    Des-gamma-carboxy Prothrombin and Alpha fetoprotein as Biomarkers for the Early Detection of Hepatocellular Carcinoma.

    Lok AS, Sterling RK, Everhart JE, Wright EC, Hoefs JC, Di Bisceglie AM, Morgan TR, Kim HY, Lee WM, Bonkovsky HL, Dienstag JL; HALT-C Trial Group.

    Gastroenterology. 2009 Oct 20. [Epub ahead of print]PMID: 19852963 [PubMed - as supplied by publisher]Related articles

    2.

    Predicting Clinical and Histologic Outcomes Based on Standard Laboratory Tests in Advanced Chronic Hepatitis C.

    Ghany MG, Lok AS, Everhart JE, Everson GT, Lee WM, Curto TM, Wright EC, Stoddard AM, Sterling RK, Di Bisceglie AM, Bonkovsky HL, Morishima C, Morgan TR, Dienstag JL; HALT-C Trial Group.

    Gastroenterology. 2009 Sep 18. [Epub ahead of print]PMID: 19766643 [PubMed - as supplied by publisher]Related articles

    3.

    Activity energy expenditure and change in body composition in late life.

    Manini TM, Everhart JE, Anton SD, Schoeller DA, Cummings SR, Mackey DC, Delmonico MJ, Bauer DC, Simonsick EM, Colbert LH, Visser M, Tylavsky F, Newman AB, Harris TB.

    Am J Clin Nutr. 2009 Nov;90(5):1336-42. Epub 2009 Sep 9.PMID: 19740971 [PubMed - in process]Related articles

    4.

    Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis C.

    Freedman ND, Everhart JE, Lindsay KL, Ghany MG, Curto TM, Shiffman ML, Lee WM, Lok AS, Di Bisceglie AM, Bonkovsky HL, Hoefs JC, Dienstag JL, Morishima C, Abnet CC, Sinha R; HALT-C Trial Group.

    Hepatology. 2009 Nov;50(5):1360-9.PMID: 19676128 [PubMed - in process]Related articles

    5.

    Non-alcoholic fatty liver disease (NAFLD) and mortality.

    Ruhl CE, Everhart JE.

    J Hepatol. 2009 Sep;51(3):593; author reply 594-5. Epub 2009 May 27. No abstract available. PMID: 19559494 [PubMed - in process]Related articles

    6.

    Weight-related effects on disease progression in the hepatitis C antiviral long-term treatment against cirrhosis trial.

    Everhart JE, Lok AS, Kim HY, Morgan TR, Lindsay KL, Chung RT, Bonkovsky HL, Ghany MG; HALT-C Trial Group.

    Gastroenterology. 2009 Aug;137(2):549-57. Epub 2009 May 13.PMID: 19445938 [PubMed - indexed for MEDLINE]Related articles

    7.

    Activity energy expenditure and mobility limitation in older adults: differential associations by sex.

    Manini TM, Everhart JE, Patel KV, Schoeller DA, Cummings S, Mackey DC, Bauer DC, Simonsick EM, Colbert LH, Visser M, Tylavsky F, Newman AB, Harris TB; Health, Aging and Body Composition Study.

    Am J Epidemiol. 2009 Jun 15;169(12):1507-16. Epub 2009 Apr 21.PMID: 19383938 [PubMed - indexed for MEDLINE]Related articles

    8.

    Evolution of hepatic steatosis in patients with advanced hepatitis C: results from the hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trial.

    Lok AS, Everhart JE, Chung RT, Kim HY, Everson GT, Hoefs JC, Greenson JK, Sterling RK, Lindsay KL, Lee WM, Di Bisceglie AM, Bonkovsky HL, Ghany MG, Morishima C; HALT-C Trial Group.

    Hepatology. 2009 Jun;49(6):1828-37.PMID: 19291787 [PubMed - indexed for MEDLINE]Related articles

    9.

    Burden of digestive diseases in the United States Part III: Liver, biliary tract, and pancreas.

    Everhart JE, Ruhl CE.

    Gastroenterology. 2009 Apr;136(4):1134-44. Epub 2009 Feb 24. Review. No abstract available. PMID: 19245868 [PubMed - indexed for MEDLINE]Related articles

    10.

    Burden of digestive diseases in the United States part II: lower gastrointestinal diseases.

    Everhart JE, Ruhl CE.

    Gastroenterology. 2009 Mar;136(3):741-54. Epub 2009 Jan 21. Review. No abstract available. PMID: 19166855 [PubMed - indexed for MEDLINE]Related articles

    11.

    Burden of digestive diseases in the United States part I: overall and upper gastrointestinal diseases.

    Everhart JE, Ruhl CE.

    Gastroenterology. 2009 Feb;136(2):376-86. Epub 2009 Jan 3. Review. No abstract available. PMID: 19124023 [PubMed - indexed for MEDLINE]Related articles

    12.

    Comparisons of percentage body fat, body mass index, waist circumference, and waist-stature ratio in adults.

    Flegal KM, Shepherd JA, Looker AC, Graubard BI, Borrud LG, Ogden CL, Harris TB, Everhart JE, Schenker N.

    Am J Clin Nutr. 2009 Feb;89(2):500-8. Epub 2008 Dec 30.PMID: 19116329 [PubMed - indexed for MEDLINE]Related articles

    13.

    Elevated serum alanine aminotransferase and gamma-glutamyltransferase and mortality in the United States population.

    Ruhl CE, Everhart JE.

    Gastroenterology. 2009 Feb;136(2):477-85.e11. Epub 2008 Oct 29.PMID: 19100265 [PubMed - indexed for MEDLINE]Related articles

    14.

    Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferon.

    Di Bisceglie AM, Shiffman ML, Everson GT, Lindsay KL, Everhart JE, Wright EC, Lee WM, Lok AS, Bonkovsky HL, Morgan TR, Ghany MG, Morishima C, Snow KK, Dienstag JL; HALT-C Trial Investigators.

    N Engl J Med. 2008 Dec 4;359(23):2429-41.PMID: 19052125 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Recipient morbidity after living and deceased donor liver transplantation: findings from the A2ALL Retrospective Cohort Study.

    Freise CE, Gillespie BW, Koffron AJ, Lok AS, Pruett TL, Emond JC, Fair JH, Fisher RA, Olthoff KM, Trotter JF, Ghobrial RM, Everhart JE; A2ALL Study Group.

    Am J Transplant. 2008 Dec;8(12):2569-79. Epub 2008 Oct 24.PMID: 18976306 [PubMed - indexed for MEDLINE]Related articles

    16.

    Interpretation of positive transcription-mediated amplification test results from polymerase chain reaction-negative samples obtained after treatment of chronic hepatitis C.

    Morishima C, Morgan TR, Everhart JE, Wright EC, Apodaca MC, Gretch DR, Shiffman ML, Everson GT, Lindsay KL, Lee WM, Lok AS, Dienstag JL, Ghany MG, Curto TM; HALT-C Trial Group.

    Hepatology. 2008 Nov;48(5):1412-9.PMID: 18816437 [PubMed - indexed for MEDLINE]Related articles

    17.

    Outcomes of living donor liver transplantation for acute liver failure: the adult-to-adult living donor liver transplantation cohort study.

    Campsen J, Blei AT, Emond JC, Everhart JE, Freise CE, Lok AS, Saab S, Wisniewski KA, Trotter JF; Adult-to-Adult Living Donor Liver Transplantation Cohort Study Group.

    Liver Transpl. 2008 Sep;14(9):1273-80.PMID: 18756453 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Long-term outcome of human leukocyte antigen mismatching in liver transplantation: results of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database.

    Balan V, Ruppert K, Demetris AJ, Ledneva T, Duquesnoy RJ, Detre KM, Wei YL, Rakela J, Schafer DF, Roberts JP, Everhart JE, Wiesner RH.

    Hepatology. 2008 Sep;48(3):878-88.PMID: 18752327 [PubMed - indexed for MEDLINE]Related articles

    19.

    Improvement in survival associated with adult-to-adult living donor liver transplantation.

    Berg CL, Gillespie BW, Merion RM, Brown RS Jr, Abecassis MM, Trotter JF, Fisher RA, Freise CE, Ghobrial RM, Shaked A, Fair JH, Everhart JE; A2ALL Study Group.

    Gastroenterology. 2007 Dec;133(6):1806-13. Epub 2007 Sep 14.PMID: 18054553 [PubMed - indexed for MEDLINE]Related articles

    20.

    Physical activity and gallbladder disease determined by ultrasonography.

    Kriska AM, Brach JS, Jarvis BJ, Everhart JE, Fabio A, Richardson CR, Howard BV.

    Med Sci Sports Exerc. 2007 Nov;39(11):1927-32.PMID: 17986899 [PubMed - indexed for MEDLINE]Related articles

    21.

    Outcomes of donor evaluation in adult-to-adult living donor liver transplantation.

    Trotter JF, Wisniewski KA, Terrault NA, Everhart JE, Kinkhabwala M, Weinrieb RM, Fair JH, Fisher RA, Koffron AJ, Saab S, Merion RM; A2ALL Study Group.

    Hepatology. 2007 Nov;46(5):1476-84.PMID: 17668879 [PubMed - indexed for MEDLINE]Related articles

    22.

    Body mass index and serum leptin concentration independently estimate percentage body fat in older adults.

    Ruhl CE, Harris TB, Ding J, Goodpaster BH, Kanaya AM, Kritchevsky SB, Simonsick EM, Tylavsky FA, Everhart JE.

    Am J Clin Nutr. 2007 Apr;85(4):1121-6.PMID: 17413114 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Prevalence of neutropenia in the U.S. population: age, sex, smoking status, and ethnic differences.

    Hsieh MM, Everhart JE, Byrd-Holt DD, Tisdale JF, Rodgers GP.

    Ann Intern Med. 2007 Apr 3;146(7):486-92.PMID: 17404350 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    Risk factors for inguinal hernia among adults in the US population.

    Ruhl CE, Everhart JE.

    Am J Epidemiol. 2007 May 15;165(10):1154-61. Epub 2007 Mar 20.PMID: 17374852 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    Hepatic steatosis in hepatitis C: comparison of diabetic and nondiabetic patients in the hepatitis C antiviral long-term treatment against cirrhosis trial.

    Lok AS, Everhart JE, Chung RT, Padmanabhan L, Greenson JK, Shiffman ML, Everson GT, Lindsay KL, Bonkovsky HL, Di Bisceglie AM, Lee WM, Morgan TR, Ghany MG, Morishima C; HALT-C Trial Group.

    Clin Gastroenterol Hepatol. 2007 Feb;5(2):245-54.PMID: 17296533 [PubMed - indexed for MEDLINE]Related articles

    26.

    Race, insulin resistance and hepatic steatosis in chronic hepatitis C.

    Conjeevaram HS, Kleiner DE, Everhart JE, Hoofnagle JH, Zacks S, Afdhal NH, Wahed AS; Virahep-C Study Group.

    Hepatology. 2007 Jan;45(1):80-7.PMID: 17187406 [PubMed - indexed for MEDLINE]Related articles

    27.

    The prevalence and risk factors associated with esophageal varices in subjects with hepatitis C and advanced fibrosis.

    Sanyal AJ, Fontana RJ, Di Bisceglie AM, Everhart JE, Doherty MC, Everson GT, Donovan JA, Malet PF, Mehta S, Sheikh MY, Reid AE, Ghany MG, Gretch DR, Halt-C Trial Group.

    Gastrointest Endosc. 2006 Dec;64(6):855-64.PMID: 17140886 [PubMed - indexed for MEDLINE]Related articles

    28.

    Epidemiologic research and the action plan for liver disease research.

    Miller ME, Everhart JE, Hoofnagle JH.

    Ann Epidemiol. 2006 Nov;16(11):861-5. Epub 2006 Oct 24. No abstract available. PMID: 17067816 [PubMed - indexed for MEDLINE]Related articles

    29.

    HCV RNA detection by TMA during the hepatitis C antiviral long-term treatment against cirrhosis (Halt-C) trial.

    Morishima C, Morgan TR, Everhart JE, Wright EC, Shiffman ML, Everson GT, Lindsay KL, Lok AS, Bonkovsky HL, Di Bisceglie AM, Lee WM, Dienstag JL, Ghany MG, Gretch DR; HALT-C Trial Group.

    Hepatology. 2006 Aug;44(2):360-7.PMID: 16871570 [PubMed - indexed for MEDLINE]Related articles

    30.

    Modifiable environmental and behavioral determinants of overweight among children and adolescents: report of a workshop.

    Johnson-Taylor WL, Everhart JE.

    Obesity (Silver Spring). 2006 Jun;14(6):929-66.PMID: 16861599 [PubMed - indexed for MEDLINE]Related articles

    31.

    Daily activity energy expenditure and mortality among older adults.

    Manini TM, Everhart JE, Patel KV, Schoeller DA, Colbert LH, Visser M, Tylavsky F, Bauer DC, Goodpaster BH, Harris TB.

    JAMA. 2006 Jul 12;296(2):171-9.PMID: 16835422 [PubMed - indexed for MEDLINE]Related articlesFree article

    32.

    Alcohol and hepatitis C: do we have a drinking problem?

    Everhart JE.

    Gastroenterology. 2006 May;130(6):1912-4. No abstract available. PMID: 16697753 [PubMed - indexed for MEDLINE]Related articles

    33.

    Joint effects of body weight and alcohol on elevated serum alanine aminotransferase in the United States population.

    Ruhl CE, Everhart JE.

    Clin Gastroenterol Hepatol. 2005 Dec;3(12):1260-8.PMID: 16361053 [PubMed - indexed for MEDLINE]Related articles

    34.

    Coffee and tea consumption are associated with a lower incidence of chronic liver disease in the United States.

    Ruhl CE, Everhart JE.

    Gastroenterology. 2005 Dec;129(6):1928-36.PMID: 16344061 [PubMed - indexed for MEDLINE]Related articles

    35.

    Is cirrhosis an inevitable consequence of chronic hepatitis C virus infection?

    Seeff LB, Everhart JE.

    Clin Gastroenterol Hepatol. 2005 Sep;3(9):840-2. No abstract available. PMID: 16234019 [PubMed - indexed for MEDLINE]Related articles

    36.

    Serum alpha-fetoprotein levels in patients with advanced hepatitis C: results from the HALT-C Trial.

    Di Bisceglie AM, Sterling RK, Chung RT, Everhart JE, Dienstag JL, Bonkovsky HL, Wright EC, Everson GT, Lindsay KL, Lok AS, Lee WM, Morgan TR, Ghany MG, Gretch DR; HALT-C Trial Group.

    J Hepatol. 2005 Sep;43(3):434-41.PMID: 16136646 [PubMed - indexed for MEDLINE]Related articles

    37.

    Outcomes of 385 adult-to-adult living donor liver transplant recipients: a report from the A2ALL Consortium.

    Olthoff KM, Merion RM, Ghobrial RM, Abecassis MM, Fair JH, Fisher RA, Freise CE, Kam I, Pruett TL, Everhart JE, Hulbert-Shearon TE, Gillespie BW, Emond JC; A2ALL Study Group.

    Ann Surg. 2005 Sep;242(3):314-23, discussion 323-5.PMID: 16135918 [PubMed - indexed for MEDLINE]Related articlesFree article

    38.

    Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: results of the HALT-C cohort.

    Lok AS, Ghany MG, Goodman ZD, Wright EC, Everson GT, Sterling RK, Everhart JE, Lindsay KL, Bonkovsky HL, Di Bisceglie AM, Lee WM, Morgan TR, Dienstag JL, Morishima C.

    Hepatology. 2005 Aug;42(2):282-92.PMID: 15986415 [PubMed - indexed for MEDLINE]Related articles

    39.

    Coffee and caffeine consumption reduce the risk of elevated serum alanine aminotransferase activity in the United States.

    Ruhl CE, Everhart JE.

    Gastroenterology. 2005 Jan;128(1):24-32.PMID: 15633120 [PubMed - indexed for MEDLINE]Related articles

    40.

    Evolution of the HALT-C Trial: pegylated interferon as maintenance therapy for chronic hepatitis C in previous interferon nonresponders.

    Lee WM, Dienstag JL, Lindsay KL, Lok AS, Bonkovsky HL, Shiffman ML, Everson GT, Di Bisceglie AM, Morgan TR, Ghany MG, Morishima C, Wright EC, Everhart JE; HALT-C Trial Group.

    Control Clin Trials. 2004 Oct;25(5):472-92.PMID: 15465617 [PubMed - indexed for MEDLINE]Related articles

    41.

    Epidemiology of nonalcoholic fatty liver.

    Ruhl CE, Everhart JE.

    Clin Liver Dis. 2004 Aug;8(3):501-19, vii. Review.PMID: 15331060 [PubMed - indexed for MEDLINE]Related articles

    42.

    Serum leptin concentrations and body adipose measures in older black and white adults.

    Ruhl CE, Everhart JE, Ding J, Goodpaster BH, Kanaya AM, Simonsick EM, Tylavsky FA, Harris TB; Health, Aging, and Body Composition Study.

    Am J Clin Nutr. 2004 Sep;80(3):576-83.PMID: 15321795 [PubMed - indexed for MEDLINE]Related articlesFree article

    43.

    Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatment.

    Shiffman ML, Di Bisceglie AM, Lindsay KL, Morishima C, Wright EC, Everson GT, Lok AS, Morgan TR, Bonkovsky HL, Lee WM, Dienstag JL, Ghany MG, Goodman ZD, Everhart JE; Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis Trial Group.

    Gastroenterology. 2004 Apr;126(4):1015-23; discussion 947.PMID: 15057741 [PubMed - indexed for MEDLINE]Related articles

    44.

    Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma.

    El-Serag HB, Tran T, Everhart JE.

    Gastroenterology. 2004 Feb;126(2):460-8.PMID: 14762783 [PubMed - indexed for MEDLINE]Related articles

    45.

    Energy requirements in the eighth decade of life.

    Blanc S, Schoeller DA, Bauer D, Danielson ME, Tylavsky F, Simonsick EM, Harris TB, Kritchevsky SB, Everhart JE.

    Am J Clin Nutr. 2004 Feb;79(2):303-10.PMID: 14749238 [PubMed - indexed for MEDLINE]Related articlesFree article

    46.

    Water turnover in 458 American adults 40-79 yr of age.

    Raman A, Schoeller DA, Subar AF, Troiano RP, Schatzkin A, Harris T, Bauer D, Bingham SA, Everhart JE, Newman AB, Tylavsky FA.

    Am J Physiol Renal Physiol. 2004 Feb;286(2):F394-401. Epub 2003 Nov 4.PMID: 14600032 [PubMed - indexed for MEDLINE]Related articlesFree article

    47.

    Maintenance therapy with ribavirin in patients with chronic hepatitis C who fail to respond to combination therapy with interferon alfa and ribavirin.

    Hoofnagle JH, Ghany MG, Kleiner DE, Doo E, Heller T, Promrat K, Ong J, Khokhar F, Soza A, Herion D, Park Y, Everhart JE, Liang TJ.

    Hepatology. 2003 Jul;38(1):66-74.PMID: 12829988 [PubMed - indexed for MEDLINE]Related articles

    48.

    Liver transplantation with hepatitis C virus-infected graft: interaction between donor and recipient viral strains.

    Fan X, Lang DM, Xu Y, Lyra AC, Yusim K, Everhart JE, Korber BT, Perelson AS, Di Bisceglie AM.

    Hepatology. 2003 Jul;38(1):25-33.PMID: 12829983 [PubMed - indexed for MEDLINE]Related articles

    49.

    Relation of elevated serum alanine aminotransferase activity with iron and antioxidant levels in the United States.

    Ruhl CE, Everhart JE.

    Gastroenterology. 2003 Jun;124(7):1821-9.PMID: 12806616 [PubMed - indexed for MEDLINE]Related articles

    50.

    A cohort study of the incidence of serious acute liver injury in diabetic patients treated with hypoglycemic agents.

    Chan KA, Truman A, Gurwitz JH, Hurley JS, Martinson B, Platt R, Everhart JE, Moseley RH, Terrault N, Ackerson L, Selby JV.

    Arch Intern Med. 2003 Mar 24;163(6):728-34.PMID: 12639207 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Search details

    » See more...